Novo Nordisk A S

NVO·NYSE·$44.19Share Price as of 11/2·$196BMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)02/04/26 20-FAnnual report (foreign)02/05/25 20-FAnnual report (foreign)01/31/24 20-FAnnual report (foreign)02/01/23 20-FAnnual report (foreign)02/02/22

Disclosures

6-KForeign issuer report10/26/26 6-KForeign issuer report10/19/26 6-KForeign issuer report10/13/26 6-KForeign issuer report10/06/26 6-KForeign issuer report10/05/26

Prospectuses and Registrations

F-6Prospectus / registration08/31/23 S-8Registration of securities for employees03/24/22 S-8Registration of securities for employees02/08/18 S-8Registration of securities for employees10/31/17 F-6 POSProspectus / registration03/02/17

Proxies

No matching filings.

Ownership

SC 13G/ABeneficial ownership (amended)06/22/26 SC 13G/ABeneficial ownership (amended)04/10/26 SC 13G/ABeneficial ownership (amended)03/04/26 SC 13G/ABeneficial ownership (amended)10/21/25 144Proposed sale of securities05/30/25

Other

11-KEmployee stock purchase plan report06/22/26 11-KEmployee stock purchase plan report06/22/26 SDConflict Minerals disclosure05/22/26 IRANNOTICEIran disclosure02/04/26 11-KEmployee stock purchase plan report06/27/25